Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the U.S. Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Dipeptidyl Peptidase 4 Inhibitors and Gallbladder or Biliary Diseases: Data From the U.S. Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	Diabetes care
Pubmed追加日	2022/12/20
投稿者	He, Liyun; Wang, Jialu; Li, Ziyi; Li, Yuxiu; Zhang, Huabing
組織名
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/36534433/